New insider activity at Irhythm Technologies ( (IRTC) ) has taken place on December 3, 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Patrick Michael Murphy, the Chief Business Officer and Chief Legal Officer of Irhythm Technologies, recently executed a significant transaction by selling 2,478 shares of the company’s stock. This sale amounted to a total value of $458,008.
Recent Updates on IRTC stock
In the last 24 hours, iRhythm Technologies has experienced significant developments impacting its stock. Morgan Stanley raised its price target for iRhythm to $205, citing the company’s strong positioning in the MedTech sector, supported by major product cycles and a favorable hospital spending environment. Despite this positive outlook, iRhythm’s stock fell by 8.5%, reflecting market reactions to ongoing challenges such as an FDA warning letter and a DOJ investigation. However, the company reported a 26% year-to-date revenue increase, driven by commercial adoption and market expansion, and is on track to achieve free cash flow positivity. Additionally, new data presented at a scientific session in Japan highlighted the consistent performance of iRhythm’s Zio monitoring service across diverse populations, further supporting its technological capabilities.
Spark’s Take on IRTC Stock
According to Spark, TipRanks’ AI Analyst, IRTC is a Neutral.
Irhythm Technologies’ overall stock score is driven by strong earnings call performance and positive technical indicators. However, significant financial challenges, including high leverage and negative profitability, weigh heavily on the score. The valuation is also unattractive due to ongoing losses.
To see Spark’s full report on IRTC stock, click here.
More about Irhythm Technologies
YTD Price Performance: 103.34%
Average Trading Volume: 428,559
Technical Sentiment Signal: Buy
Current Market Cap: $5.86B